At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HCC Warrior Met Coal LLC
Market Closed 12-12 16:00:00 EST
83.41
-0.71
-0.84%
盘后83.41
+0.000.00%
19:49 EST
High85.32Low81.16Vol649.06K
Open84.91D1 Closing84.12Amplitude4.95%
Mkt Cap4.38BTradable Cap4.29BTotal Shares52.57M
T/O54.02MT/O Rate1.26%Tradable Shares51.47M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Warrior Met Coal Is Maintained at Neutral by UBS
Dow Jones  ·  12-13 05:52
Warrior Met Coal Is Maintained at Neutral by UBS
Discover 3 Stocks Priced Below Estimated Value
Simply Wall St.  ·  12-09
Discover 3 Stocks Priced Below Estimated Value
Warrior Met Coal Inc : Jefferies Raises Target Price to $95 From $85
THOMSON REUTERS  ·  12-08
Warrior Met Coal Inc : Jefferies Raises Target Price to $95 From $85
U.S. RESEARCH ROUNDUP- Apple, Cooper Companies, Sandisk
Reuters  ·  12-08
U.S. RESEARCH ROUNDUP- Apple, Cooper Companies, Sandisk
The Bull Case For Warrior Met Coal (HCC) Could Change Following Broad-Based Surge In Steelmaking Coal Demand - Learn Why
Simply Wall St.  ·  12-07
The Bull Case For Warrior Met Coal (HCC) Could Change Following Broad-Based Surge In Steelmaking Coal Demand - Learn Why
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
GlobeNewswire  ·  12-06
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Lyft And 2 Other Stocks That May Be Trading Below Fair Value Estimates
Simply Wall St.  ·  12-03
Lyft And 2 Other Stocks That May Be Trading Below Fair Value Estimates
Zymeworks Announces Participation in Upcoming Conferences
GlobeNewswire  ·  12-03
Zymeworks Announces Participation in Upcoming Conferences
3 Prominent Stocks Estimated To Be Undervalued By At Least 40.2%
Simply Wall St.  ·  12-02
3 Prominent Stocks Estimated To Be Undervalued By At Least 40.2%
How Investors May Respond To Warrior Met Coal (HCC) Surpassing Q3 Estimates and Gaining Analyst Interest
Simply Wall St.  ·  11-28
How Investors May Respond To Warrior Met Coal (HCC) Surpassing Q3 Estimates and Gaining Analyst Interest
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
GlobeNewswire  ·  11-26
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Warrior Met Coal (HCC) Receives a New Rating from Texas Capital Securities
TIPRANKS  ·  11-25
Warrior Met Coal (HCC) Receives a New Rating from Texas Capital Securities
HENLIUS (02696): First Patient Dosed in China for International Phase 1 Clinical Study of HLX13 (Ipilimumab Biosimilar) in First-Line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Stock News  ·  11-25
HENLIUS (02696): First Patient Dosed in China for International Phase 1 Clinical Study of HLX13 (Ipilimumab Biosimilar) in First-Line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Warrior Met Coal Is Maintained at Neutral by UBS
Dow Jones  ·  11-24
Warrior Met Coal Is Maintained at Neutral by UBS
UBS Adjusts Price Target on Warrior Met Coal to $80 From $75, Maintains Neutral Rating
MT Newswires Live  ·  11-24
UBS Adjusts Price Target on Warrior Met Coal to $80 From $75, Maintains Neutral Rating
Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference
GlobeNewswire  ·  11-24
Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference
Warrior Met Coal Inc : UBS Raises Target Price to $80 From $75
THOMSON REUTERS  ·  11-24
Warrior Met Coal Inc : UBS Raises Target Price to $80 From $75
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson
GlobeNewswire  ·  11-18
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
Simply Wall St.  ·  11-17
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025
Warrior Met Coal Chief Accounting Officer Brian M. Chopin Reports Sale of Common Shares
Reuters  ·  11-15
Warrior Met Coal Chief Accounting Officer Brian M. Chopin Reports Sale of Common Shares

Introduction

Company Name.
Warrior Met Coal LLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.
Issue price:
--